Simple and reliable detection of slime production of Candida spp. directly from blood culture bottles: Comparison of visual tube method and transmission electron microscopy

Mycopathologia

Volumn 158, Issue 3, 2004, Pages 279-284

  Cerikcioglu, Nilgun ^a   Hasdemir, Ufuk Over ^a   San, Tangul ^a   Salik, Emsal ^a   Soyletir, Guner ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Blood culture; Candida spp.; Slime production

Indexed keywords

ARTICLE; BLOOD; CANDIDA; CANDIDIASIS; COMPARATIVE STUDY; CULTURE MEDIUM; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MYCOLOGY; STANDARD; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

BLOOD; CANDIDA; CANDIDIASIS; CULTURE MEDIA; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOLOGY;

CANDIDA;

EID: 12844259171     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-004-0927-4     Document Type: Article

References (33)

1. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32: 452-456.
2. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
3. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001; 33: 1387-1392.
4. Girmenia C, Martino P, Bernardis FD, Gentile G, Boccanera M, Monaco M, Antonucci G, Cassone A. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996; 23: 506-514.
5. Jong HS, Seung JK, Myung GS, Soo HK, Dong HS, Sang KL, Soon PS, Dong WR. Biofilm production by isolates of Candida species recovered from non-neutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 2002; 40: 1244-1248.
6. Baillie GS, Douglas J. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46: 397-403.
7. Hawser SP, Douglas J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 1994; 62: 915-921.
8. Hawser SP, Douglas J. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995; 39: 2128-2131.
9. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995; 39: 2397-2400.
10. Grosserode MH, Wenzel RP. The continuing importance of staphylococci as major hospital pathogens. J Hosp Infect 1991; 19 Suppl B: 3-17.
11. Kloos WE, Bannerman TL. Update on clinical significance of coagulase negative staphylococci. Clin Microbiol Rev 1994; 7: 117-40.
12. Arciola CR, Montanaro L, Baldassarri L, Borsetti E, Cavedagna D, Donati E. Slime production by staphylococci isolated from prosthesis- associated infections. New Microbiol 1999; 22: 337-41.
13. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. The Calgary biofilm device: New technology for rapid determination of antibiotic suspectibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
14. Stewart PS. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996; 40: 2517-2522.
15. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Ann Rev Microbiol 1995; 49: 711-745.
16. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The Involvement of cell - to- cell signals in the development of bacteral biofilms. Science 1998; 280: 295-298.
17. Wilson M. Susceptibility of oral bacterial biofilms to antimicrobial agents. J Med Microbiol 1996; 44: 79-87.
18. Davenport DS, Massanari RM, Pfaller MA, Bale MJ, Streed SA, Hierholzer WJ. Usefulness of a test for slime production as a marker for clinically significant infections with coagulase-negative staphylococci. J Infect Dis 1986; 153: 332-339.
19. Sohnle PG, Hahn BL, Erdmann MD. Effect of fluconazole on viability of Candida albicans over extended periods of time. Antimicrob Agents Chemother 1996; 40: 2622-2625.
20. Luft HJ. Ruthenium red and violet. II. Fine structural localization in animal tissues. Anat Rec 1971; 171: 369-416.
21. Reynolds E. The use of the lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 1963; 17: 208-212.
22. Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 2003; 149(Pt 2): 353-362.
23. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 2002; 70: 878-888.
24. Westergren G, Olsson J. Hydrophobicity and adherence of oral streptococci after repeated subculture in vitro. Infect Immun 1983; 40: 432-435.
25. Koga T, Asakawa H, Okahashi N, Takahashi I. Effect of subculturing on expression of a cell-surface protein antigen by Streptococcus mutans. J Gen Microbiol 1989; 135 (pt 12): 3199-4207.
26. Christensen GD, Baddour LM, Simpson WA. Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. Infect Immun 1987; 55: 2870-2877.
27. Rohde H, Knobloch JK, Horstkotte MA, Marck D. Correlation of biofilm expression types of Staphylococcus epidermidis with polysaccharide intercellular adhesin synthesis: evidence for involvemend of icaADBC genotype-independent factors. Med Microbiol Immunol (Berl) 2001; 190: 105-112.
28. Nikawa H, Nishimura H, Hamada T, Kumagai H, Samaranayake LP. Effects of dietary sugars and, saliva and serum on Candida biofilm formation on acrylic surfaces. Mycopathologia 1997; 139: 87-91.
29. Nikawa H, Nishimura H, Makihira S, et al. Effect of serum concentration on Candida biofilm formation on acrylic surfaces. Mycoses 2000; 43(3-4): 139-143.
30. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-36.
31. Lazzarani L, Luzzati R. Removal of central venous catheters from patients with candidemia. Clin Infect Dis 2002; 35: 1021.
32. Walsh JT, Rex JH. All catheter related candidemia is not the same: assessement of the balance between the risks and benefits of removal of vascular catheters. Clin Infect Dis 2002; 34: 600-602.
33. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002; 34: 591-599.